SILYBON- 70
Manufacturer Details
MICRO LABS
Compositions:
Silymarin 70mg/140mg tabs 35mg/ml tablets,
Silymarin 35mg/5ml suspension,
|
Strength
|
Rate
|
Packing Style
|
|
70mg
|
87.00
|
10s tablets
|
|
140mg
|
128.00
|
10s tablets
|
|
35mg/5ml
|
127.85
|
100ml suspn
|
List of Related Indications:
- Cirrhosis of liver
- Liver dysfunction
List Of Drugs:
- Silymarin - Hepatobiliary agent- (June 1995)
Indication Type Description:
Drug Interaction:
None reported.
Indication:
Chronic active hepatitis
New Drugs Approved by (DCI) Drug Controller GENERAL - India For Marketing
(Ref- IDMA Publication)
Name of Drug Indication Date of Approval
Silymarin Hepatoprotective June 1995
Adverse Reaction:
Occasional laxative effect.
Contra-Indications:
H/O hypersensitivity,pregnancy and lactation.
Special precautions:
Safety in pregnancy, lactation, and in children not established.
Dosages/ Overdosage Etc:
Date of Approval - June 1995
Indication-
Chronic active hepatitis
Dosage-
70mg 2- 3 times daily Severe cases (serum bilirubin ) over 10mg- 140mg 2- 3 times daily for 6 weeks or as required
